Primary |
Hypertonic Bladder |
80.0% |
Urinary Incontinence |
20.0% |
|
Gastritis |
23.1% |
Swollen Tongue |
15.4% |
Drug Ineffective |
7.7% |
Food Interaction |
7.7% |
Inappropriate Schedule Of Drug Administration |
7.7% |
Memory Impairment |
7.7% |
Prostate Cancer |
7.7% |
Somnolence |
7.7% |
Urinary Retention |
7.7% |
Vertigo |
7.7% |
|
Secondary |
Product Used For Unknown Indication |
44.8% |
Drug Use For Unknown Indication |
15.2% |
Cardiac Failure |
4.8% |
Hypertension |
4.0% |
Chemotherapy |
3.2% |
Prophylaxis |
3.2% |
Conjunctivitis |
2.4% |
Hyperuricaemia |
2.4% |
Incontinence |
2.4% |
Pain |
2.4% |
Prophylaxis Of Nausea And Vomiting |
2.4% |
Thrombosis Prophylaxis |
2.4% |
Vomiting |
2.4% |
Appetite Disorder |
1.6% |
Atrial Fibrillation |
1.6% |
Hypertonic Bladder |
1.6% |
Bladder Disorder |
0.8% |
Depression |
0.8% |
Hallucination, Visual |
0.8% |
Insomnia |
0.8% |
|
Completed Suicide |
24.1% |
Stevens-johnson Syndrome |
10.3% |
White Blood Cell Count Decreased |
6.9% |
Bradycardia |
3.4% |
Drug Rash With Eosinophilia And Systemic Symptoms |
3.4% |
Drug Toxicity |
3.4% |
Hypoglycaemia |
3.4% |
Multiple Drug Overdose Intentional |
3.4% |
Muscle Spasms |
3.4% |
Poisoning |
3.4% |
Somnolence |
3.4% |
Stupor |
3.4% |
Suicidal Ideation |
3.4% |
Suicide Attempt |
3.4% |
Toxicity To Various Agents |
3.4% |
Urinary Retention |
3.4% |
Vertigo |
3.4% |
Vision Blurred |
3.4% |
Vomiting |
3.4% |
Wrong Drug Administered |
3.4% |
|
Concomitant |
Product Used For Unknown Indication |
34.1% |
Drug Use For Unknown Indication |
22.9% |
Rheumatoid Arthritis |
5.8% |
Depression |
5.7% |
Hypertension |
4.7% |
Multiple Sclerosis |
3.1% |
Pain |
3.0% |
Prophylaxis |
3.0% |
Osteoarthritis |
2.2% |
Hypertonic Bladder |
1.9% |
Parkinson's Disease |
1.6% |
Prostate Cancer |
1.6% |
Bipolar Disorder |
1.5% |
Benign Prostatic Hyperplasia |
1.4% |
Blood Cholesterol Increased |
1.4% |
Constipation |
1.4% |
Knee Arthroplasty |
1.4% |
Urinary Tract Infection |
1.3% |
Anxiety |
1.0% |
Osteoporosis |
1.0% |
|
Vision Blurred |
10.8% |
Vomiting |
8.8% |
Sleep Disorder |
6.9% |
Transient Ischaemic Attack |
6.9% |
Hallucination |
5.9% |
Interstitial Lung Disease |
5.9% |
Weight Increased |
5.9% |
Dizziness |
4.9% |
Mobility Decreased |
4.9% |
Pain In Jaw |
3.9% |
Pneumonia |
3.9% |
Rectal Haemorrhage |
3.9% |
Skin Hyperpigmentation |
3.9% |
Stupor |
3.9% |
Urinary Tract Infection |
3.9% |
White Blood Cell Count Decreased |
3.9% |
Atrial Fibrillation |
2.9% |
Drug Toxicity |
2.9% |
Multiple Sclerosis Relapse |
2.9% |
Pseudolymphoma |
2.9% |
|
Interacting |
Drug Use For Unknown Indication |
82.6% |
Abdominal Pain Upper |
8.7% |
Bladder Disorder |
8.7% |
|
|